GERNW GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)

添加自選

1.740
+0.004+0.23%

延時15分鐘行情交易中 07/22 11:01 (美東)

0總市值0.00市盈率TTM

關於GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)公司

傑龍公司是一家臨牀階段生物製藥公司，專注於研究和開發癌症治療藥物。公司的在研藥物 Imelstat 正在接受測試，用於治療骨髓增生異常綜合徵，一種血液疾病，和骨髓纖維化，一種影響骨髓的罕見血癌。公司通過合作協議，里程碑，版稅和許可安排獲得收入。傑龍擁有該藥物的各種權利。該公司的業務只有一個分部，即開發腫瘤治療產品。

公司介紹

公司代碼GERNW

公司名稱GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)

上市日期1996/07/30

成立日期1990

CEODr. John A. Scarlett,M.D.

所屬市場粉單

員工數量141

證券類型海外普通股

年結日12-31

公司地址919 East Hillsdale Boulevard,Suite 250

城市Foster City

省份加利福尼亞州

國家美國

郵編94404

電話1-650-473-7700

網址http://www.geron.com

董事高管

姓名
職務
年薪

Dr. John A. Scarlett,M.D.
Chairman of the Board, Chief Executive Officer and President
492.41萬

Michelle Robertson
Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
246.97萬

Dr. Andrew J. Grethlein,PhD
Executive Vice President and Chief Operating Officer
241.51萬

Shannon T. Odam
Senior Vice President and Chief People Officer
--

Scott A. Samuels
Executive Vice President, Chief Legal Officer and Corporate Secretary
360.87萬

Dr. Faye Feller
Executive Vice President and Chief Medical Officer
--

Melissa A. Kelly Behrs
Executive Vice President, Business Operations and Chief Alliance Officer
--

Edward E. Koval
Executive Vice President and Chief Business Officer
--

Anil Kapur
Executive Vice President, Corporate Strategy and Chief Commercial Officer
--

Dr. V. Bryan Lawlis, PhD
Independent Director
36.09萬

Elizabeth G. O’Farrell
Lead Independent Director
37.55萬

Dr. Robert J. Spiegel, F.A.C.P.,M.D.
Independent Director
35.09萬

Dawn Carter Bir
Independent Director
34.31萬

Dr. Susan M. Molineaux, PhD
Independent Director
34.59萬

John F. McDonald
Independent Director
34.84萬

Dr. Gaurav Aggarwal, M.D.
Independent Director
29.08萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度